US FDA approves GSK's Boostrix to prevent whooping cough in newborns
(Alliance News) - GSK PLC on Monday said Boostrix has been approved by the US Food & Drug Administration for immunisation during the third trimester of pregnancy to help prevent pertussis in infants less than two months of age. Read More